National Center for Advancing Translational Sciences; Notice of Meeting, 48746 [2021-18727]

Download as PDF 48746 Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices Director who reports to the Assistant Secretary for Health. 2. OCCHE shall work with the Immediate Office of the Secretary, Staff Divisions, and Operating Divisions to focus on: —Identifying communities with disproportionate exposures to climate hazards and vulnerable populations. —Addressing health disparities exacerbated by climate impacts to enhance community health resilience. —Promoting and translating research on public health benefits of multisectoral climate actions. —Supporting regulatory efforts to reduce greenhouse gas emissions and criteria air pollution throughout the health care sector, including participating suppliers and providers. —Fostering innovation in climate adaptation and resilience for people and communities experiencing a disproportionate share of climate impacts and health inequities. —Providing expertise and coordination to the White House and other Federal agencies related to climate change and health equity deliverables and activities, including executive order implementation, and reporting on health adaptation actions under the United Nations Framework Convention on Climate Change. —Promoting training opportunities to build the climate and health workforce and empower communities. —Exploring opportunities to partner with the philanthropic and private sectors to support innovative programming to address disparities and health sector transformation. Delegations of Authority khammond on DSKJM1Z7X2PROD with NOTICES Directives or orders made by the Secretary or the Assistant Secretary for Health, including all delegations and redelegations of authority made to officials and employees of affected organizational components will continue in force pending further delegation, if allowed, provided they are consistent with this realignment. Andrea Palm, Deputy Secretary. [FR Doc. 2021–18794 Filed 8–30–21; 8:45 am] BILLING CODE 4150–03–P VerDate Sep<11>2014 20:08 Aug 30, 2021 Jkt 253001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Center for Advancing Translational Sciences Advisory Council. The meeting will be open to the public as indicated below. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (http:// videocast.nih.gov). Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Advisory Council. Date: September 23–24, 2021. Closed: September 23, 2021, 10:30 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting). Open: September 23, 2021, 1:00 p.m. to 5:00 p.m. Agenda: Report from the Institute Director and other staff. Place: National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting). Open: September 24, 2021, 1:00 p.m. to 5:00 p.m. Agenda: To view and discuss Clearance of Concepts. Place: National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 for Advancing Translational Sciences, One Democracy Plaza, Room 1072, Bethesda, MD 20892, 301–435–0809, anna.ramseyewing@ nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice no later than 15 days after the meeting at NCATSCouncilInput@ mail.nih.gov. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: August 25, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–18727 Filed 8–30–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; Evaluation of Office of Acquisitions System (OASYS) and FFRDC Contract Administration System (FCAS) Vendor Portals National Cancer Institute (NCI) AGENCY: National Institutes of Health, HHS. ACTION: Notice. In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. DATES: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Marla Jacobson, 9609 Medical Center Drive, MSC 9742, Rockville, MD 20850 or call non-toll-free number 240–276– SUMMARY: E:\FR\FM\31AUN1.SGM 31AUN1

Agencies

[Federal Register Volume 86, Number 166 (Tuesday, August 31, 2021)]
[Notices]
[Page 48746]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18727]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Center for 
Advancing Translational Sciences Advisory Council.
    The meeting will be open to the public as indicated below. The open 
session will be videocast and can be accessed from the NIH Videocasting 
and Podcasting website (http://videocast.nih.gov). Individuals who need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the Contact Person listed 
below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Advisory Council.
    Date: September 23-24, 2021.
    Closed: September 23, 2021, 10:30 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, 6701 Democracy 
Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting).
    Open: September 23, 2021, 1:00 p.m. to 5:00 p.m.
    Agenda: Report from the Institute Director and other staff.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, 6701 Democracy 
Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting).
    Open: September 24, 2021, 1:00 p.m. to 5:00 p.m.
    Agenda: To view and discuss Clearance of Concepts.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, 6701 Democracy 
Boulevard, Room 987/989, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive 
Secretary, National Center for Advancing Translational Sciences, One 
Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809, 
[email protected].
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice no later than 15 days after the meeting at 
[email protected]. The statement should include the 
name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: August 25, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-18727 Filed 8-30-21; 8:45 am]
BILLING CODE 4140-01-P